Lentiviral Vector CDMOs with Clean FDA Inspection History

← All Lentiviral CDMOs Best Clean FDA History Commercial Scale

CDMOs tracked

Fully scored

With FDA records

FDA inspections

EMA/MHRA GMP certs

Lentiviral vectors are the workhorse of ex vivo gene therapy, used to engineer T cells for CAR-T and to modify hematopoietic stem cells. Because the vector ends up in patient-bound cells, manufacturers carry the regulatory weight of a critical starting material under full GMP.

Choosing a lentiviral vector CDMO comes down to BSL-2 containment, a mature suspension or adherent platform, robust analytics (titer, potency, RCL testing), and a clean regulatory record. The rankings below score each CDMO on FDA inspection history, GMP certification, clinical-program activity, and capacity signals.

FDA inspection outcomes across these CDMOs: 11 NAI (no action), 16 VAI (voluntary action), 0 OAI (official action). Leading inspection & GMP sites: UNITED KINGDOM (35), United States (26), Denmark (18), Germany (8), France (7).

Last updated 2026-05-27. Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

#	CDMO	Signal Score	Quality	FDA · GMP	Capacity	Programs
1	CR Charles River Laboratories Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD	91.7	98.7	7 insp · 11 GMP	Limited	0 programs
2	RP ReciBioPharm Keele, UK · Sodertalje, SE	88.0	100.0	0 insp · 3 GMP	—	0 programs
3	PB Pharmaron Biologics San Diego, CA · Shaoxing, CN	85.6	100.0	3 insp · 0 GMP	—	0 programs
4	TF Thermo Fisher Scientific Plainville, MA · Alachua, FL · Cambridge, MA	83.1	97.9	5 insp · 10 GMP	Available	2 programs
5	BR BioReliance (Merck) Glasgow, UK · Rockville, MD	81.0	98.8	2 insp · 8 GMP	—	0 programs
6	AG AGC Biologics Longmont, CO · Milan, IT · Copenhagen, DK · Chiba, JP	80.6	99.9	1 insp · 23 GMP	Available	2 programs
7	OB OmniaBio Hamilton, ON	79.5	100.0	0 insp · 2 GMP	—	0 programs
8	PG ProBioGen Berlin, DE	78.9	100.0	0 insp · 2 GMP	—	0 programs
9	Lonza Basel, Switzerland	78.2	95.1	2 insp · 8 GMP	—	1 programs
10	AA Ascend Advanced Therapies Philadelphia, PA	78.1	100.0	0 insp · 1 GMP	—	0 programs
11	NG NecstGen Leiden, NL	78.1	100.0	0 insp · 1 GMP	—	0 programs
12	ET Exothera Jumet, BE	78.1	100.0	0 insp · 4 GMP	—	0 programs
13	AD Advent Bioservices London, UK	78.1	100.0	0 insp · 2 GMP	—	0 programs
14	BV Biovian Turku, Finland	78.0	99.7	1 insp · 4 GMP	—	0 programs
15	AG2 August Bioservices San Carlos, CA	77.4	98.5	1 insp · 0 GMP	—	0 programs
16	OX Oxford Biomedica Oxford, United Kingdom	77.1	100.0	0 insp · 13 GMP	Available	7 programs
17	CI Cincinnati Children's Vector Production Facility Cincinnati, OH	75.2	100.0	1 insp · 0 GMP	—	1 programs
18	LZ Lonza Biologics Houston, TX · Portsmouth, NH · Geleen, NL · Basel, CH	72.8	95.1	1 insp · 0 GMP	Limited	0 programs
19	GZ Genezen Indianapolis, IN · Lexington, MA	70.7	84.1	3 insp · 0 GMP	Available	0 programs

How we score CDMOs →

What to evaluate in a Lentiviral Vector CDMO

Containment & biosafety

Lentivirus requires BSL-2 manufacturing with segregated suites and validated decontamination. Confirm the site's containment design and replication-competent lentivirus (RCL) testing strategy.

Process platform maturity

Suspension culture scales more cleanly than adherent for larger batches. Ask whether the platform is serum-free and how it performs at your target dose and patient volume.

Analytics & potency

Titer, infectivity, and potency assays drive lot release. A CDMO with qualified, established assays de-risks comparability and tech transfer.

Regulatory track record

Cross-check FDA 483 history and EMA/MHRA GMP coverage — both are shown in the rankings above and on each profile.

Lentiviral Vector CDMOs — Frequently Asked Questions

Who are the top Lentiviral Vector CDMOs?

By CDMO Signal's independent Signal Score, the top-ranked Lentiviral Vector CDMOs include Charles River Laboratories, ReciBioPharm, Pharmaron Biologics. See the full ranked table above — scored on FDA, clinical, financial, and capacity data.

How many Lentiviral Vector CDMOs have FDA inspection records?

CDMO Signal tracks 11 Lentiviral Vector CDMOs with FDA inspection records and 92 EMA/MHRA GMP certificates across the group.

What should I look for in a lentiviral vector CDMO?

Prioritize BSL-2 containment, a mature suspension platform, qualified titer/potency/RCL assays, and a clean FDA and EMA/MHRA record. Match capacity to your dose and patient volume, and confirm tech-transfer support.

How is lentiviral vector manufacturing different from AAV?

Lentivirus integrates into the host genome and is produced under BSL-2 with RCL testing, typically for ex vivo cell engineering. AAV is non-integrating, made at higher volumes, and used mainly for in vivo gene therapy.

Related modalities

Cell Therapy CDMOs CAR-T CDMOs AAV / Gene Therapy CDMOs

Other Modalities

AAV CAR-T Cell Therapy mRNA/LNP Plasmid DNA Biologics Oligo/ASO Adenoviral Gene Editing Exosome Recombinant Proteins ADC